A continuous dosing respiratory device

Abstract

The utility model discloses a kind of sustained drug delivery formula breath wearers, including wearing main body and doser;Wearing main body includes cover body, cover body includes two extension face-pasting layers and fit layer, any extension face-pasting layer is equipped with hanging ear slot, fit layer includes the bulge chamber for covering oral cavity and nasal cavity, the fit periphery around the bulge chamber outer circumferential face cheek, at least one air hole is formed on the cavity wall of bulge chamber;At least one extension face-pasting layer is equipped with exposed doser loading part for detachable type carrying doser, doser loading part is equipped with through window, which is communicated with bulge chamber and extends through extension face-pasting layer;Doser is arranged in doser loading part, and doser has exposed medicine outlet end, which is matched with through window opposite position.This utility model wearing main body can realize the carrying of doser, and the wearing comfort is better and more beautiful.The wearing fit support and comfort are guaranteed, and it is suitable for various population wearing.

Description

Technical Field

[0001] This utility model relates to a continuous drug delivery breathing device, belonging to the technical field of wearable drug delivery devices. Background Technology

[0002] The rising incidence of respiratory diseases in recent years has seriously impacted people's health and quality of life. Currently, traditional drug administration methods for respiratory diseases in the medical field mainly include oral administration, injection, and single-use mucosal administration. Injection includes intramuscular and intravenous injection. While oral administration is convenient, the drug diffuses through the gastrointestinal mucosa into the bloodstream, reaching the affected area to exert its effect. Reaching the lesion site requires time and is easily affected by various enzymes and pH levels in the gastrointestinal tract. Furthermore, incomplete absorption in the small intestine can slow down or reduce the drug's efficacy. Therefore, oral administration sometimes fails to achieve effective treatment. Injection, the drug slowly enters the bloodstream from the muscle layer. Absorption is faster in areas with richer blood vessels, resulting in faster absorption than oral administration. However, injection has greater side effects than oral administration, such as tissue damage, local pain, potential complications, and rapid onset of adverse reactions. Although single-dose nasal mucosal administration can bypass the blood-brain barrier and achieve rapid onset of action through absorption via the nasal mucosa, current nasal mucosal administration methods almost all adopt the form of invasive sprays. This form of administration has a shorter duration of effect, and the invasive form of administration may bring other risks.

[0003] In response to this situation, the applicant filed a Chinese invention patent with authorization announcement number CN116570804B, which discloses a flexible drug delivery stent that meets the requirements for mounting the drug core mechanism. However, the space for mounting the drug core mechanism is relatively limited, and the nose and cheeks are affected by a certain amount of weight, resulting in poor wearing comfort. In particular, it is difficult to achieve built-in mounting when mounting an atomizer with a power supply device.

[0004] Chinese utility model patent CN213158587U discloses a micro-mesh atomizer that achieves automated atomization through the combination of a wearing component and the atomizer body, meeting the application scenario of freeing up the hands. This structure can accommodate atomizers with a power source; however, the atomizer body is also located at the front of the mask body. Its suspension at the front of the mask body exerts a significant force on the mask body, greatly affecting facial comfort and the wearer's facial aesthetics, resulting in a poor user experience. Furthermore, the mask body's internal space is covered by the outer perimeter, significantly impacting wearing comfort, and the strap-style wearing method can easily cause fatigue. Utility Model Content

[0005] The purpose of this invention is to address the shortcomings of the existing technology and to propose a continuous drug delivery respiratory wearer that addresses the problem of unreasonable design of the mounting position and cover of traditional nebulizers affecting wearing comfort.

[0006] To achieve the above objectives, the technical solution adopted by this utility model is as follows:

[0007] A continuous drug delivery respiratory wearable device includes a wearable body and a drug delivery device;

[0008] The wearing body includes a cover, which includes a fitting layer and two extended face-fitting layers disposed on the fitting layer. Each of the extended face-fitting layers has an ear-hook slot. The fitting layer includes a raised chamber for covering the oral cavity and nasal cavity, and a fitting periphery surrounding the raised chamber and fitting the cheek. The wall of the raised chamber has at least one ventilation channel. At least one of the extended face-fitting layers has an exposed drug delivery device loading part for detachably mounting the drug delivery device. The drug delivery device loading part has a through window that connects the extended face-fitting layer and the raised chamber.

[0009] The drug delivery device is disposed within the drug delivery device loading section, and the drug delivery device has an exposed dispensing end that is aligned and matched with the through-window.

[0010] Preferably, the outer edge of the fitting periphery adjacent to the raised cavity is provided with a first nasal bridge conforming fitting groove and two fitting skirts provided on both sides of the first nasal bridge conforming fitting groove.

[0011] Preferably, a second nasal bridge contouring groove is provided at one end of the outer periphery of the fitting that is away from the raised cavity, and a concave cavity is provided on the outer periphery of the fitting that is located between the first nasal bridge contouring groove and the second nasal bridge contouring groove.

[0012] Preferably, the drug delivery device loading portion includes a raised outer peripheral wall disposed on the extended face patch, and a loading groove for loading the drug delivery device is formed in the raised outer peripheral wall;

[0013] At least one anti-mistake fitting rib is provided on the inner ring wall of the protruding outer peripheral wall, and the drug delivery device is provided with anti-mistake fitting grooves that correspond one-to-one with the anti-mistake fitting ribs.

[0014] Preferably, the drug delivery device includes a control host and an nebulizer body disposed on the control host. The nebulizer body has an nebulizer base and a drug chamber for supplying liquid medicine to the nebulizer base. The drug outlet is an nebulizing plate disposed on the nebulizer base. The nebulizing plate is electrically connected to the control host. The drug chamber has a supply channel for supplying liquid medicine to the nebulizing plate.

[0015] Preferably, the atomizer body is detachably connected to the control host.

[0016] Preferably, the medicine container is detachably connected to the nebulizer base.

[0017] Preferably, the wearing body is an integrally molded structural component consisting of the adhesive layer, the extended face-fitting layer, and the drug delivery device loading part.

[0018] The beneficial effects of this utility model are mainly reflected in:

[0019] 1. The main body can accommodate the drug delivery device, and it is comfortable and aesthetically pleasing to wear.

[0020] 2. This ensures a snug fit, support, and comfort, making it suitable for all types of people.

[0021] 3. The one-piece molding method facilitates mass production, while the assembly process is convenient, efficient, and flexible. Attached Figure Description

[0022] Other features, objects, and advantages of this application will become more apparent from the following detailed description of non-limiting embodiments with reference to the accompanying drawings:

[0023] Figure 1 This is a schematic diagram of the wearing structure of a continuous drug delivery breathing device according to this utility model.

[0024] Figure 2 This is a schematic diagram of the structure of a continuous drug delivery breathing device according to this utility model.

[0025] Figure 3 This is an exploded structural diagram of a continuous drug delivery breathing device according to this utility model.

[0026] Figure 4 This is a schematic diagram of the main body of a continuous drug delivery respiratory wearer according to this utility model.

[0027] Figure 5 This is a schematic diagram of the wearing body from another perspective in a continuous drug delivery respiratory wearer according to this utility model.

[0028] Figure 6 This is a schematic diagram of the drug delivery device in a continuous drug delivery breathing device according to this utility model. Detailed Implementation

[0029] To make the objectives, technical solutions, and advantages of the embodiments of this utility model clearer, the technical solutions of the embodiments of this utility model will be clearly and completely described below with reference to the accompanying drawings. Obviously, the described embodiments are only some embodiments of this utility model, not all embodiments. Based on the embodiments of this utility model, all other embodiments obtained by those skilled in the art without creative effort are within the protection scope of this utility model.

[0030] The present application will now be described in further detail with reference to the accompanying drawings and embodiments. It should be understood that the specific embodiments described herein are merely illustrative of the relevant utility model and not intended to limit the utility model. Furthermore, it should be noted that, for ease of description, only the parts relevant to the utility model are shown in the accompanying drawings. It should be noted that, unless otherwise specified, the embodiments and features described in the present application can be combined with each other.

[0031] This invention provides a continuous drug delivery respiratory wearable device, such as... Figures 1 to 6 As shown, it includes a wearable body 100 and a drug delivery device 200.

[0032] The wearing body 100 includes a cover, which includes a fitting layer 1 and two extended face-fitting layers 2 disposed on the fitting layer 1. Each extended face-fitting layer 2 is provided with an ear-hook slot 20. The fitting layer 1 includes a raised cavity 3 for covering the oral cavity and nasal cavity, and a fitting periphery 4 surrounding the raised cavity 3 and fitting the cheek. At least one ventilation channel 30 is provided on the cavity wall of the raised cavity 3. At least one extended face-fitting layer 2 is provided with an exposed drug delivery device loading part 5 for detachably mounting a drug delivery device 200. The drug delivery device loading part 5 is provided with a through window 50 that penetrates the extended face-fitting layer and communicates with the raised cavity 3.

[0033] The drug delivery device 200 is disposed inside the drug delivery device loading section, and the drug delivery device has an exposed dispensing end 300 that is aligned with the through opening.

[0034] Detailed implementation process and principle explanation:

[0035] The drug delivery device 200 is a drug delivery device, which includes a volatile drug dispenser and a nebulizer. Any device that can deliver drugs into the raised chamber 3 is within the scope of protection of this case.

[0036] The main body 100 is used to carry the drug delivery device 200 and is worn on the face. It generally adopts a mask-like structure, that is, it covers the lower half of the face, the nasal cavity and the oral cavity, leaving the upper half exposed, which is convenient to wear.

[0037] In the specific design, the outer periphery 4 is used to ensure a stable fit with the cheek, so that the raised cavity is suspended and its internal space is guaranteed. At the same time, the design of the extended face-fitting layer 2 is adopted, and the drug delivery device loading part 5 is mounted on the side opposite the face. This makes it more aesthetically pleasing when worn. After the drug delivery device 200 is mounted, the drug delivery device loading part 5 will be affected by the gravity of the drug delivery device 200, which will exert a certain force on the wearing body 100. Since it is set on the extended face-fitting layer 2, there is a large stability between the extended face-fitting layer 2 and the face when worn, which meets the load requirements of the drug delivery device and the overall wearing comfort is better.

[0038] In one specific embodiment, a first nasal bridge contouring groove 41 and two contouring skirts 410 are provided on the edge adjacent to the outer periphery 4 and the raised cavity 3.

[0039] Specifically, the first nose bridge contouring groove 41 can achieve a contoured fit with the nose bridge, making the fit more reliable and stable, while the fitting skirt 410 is used to fit on the cheek, providing elastic support and improving comfort.

[0040] In one specific embodiment, a second nasal bridge contouring groove 42 is provided at one end of the outer periphery 4 away from the raised cavity 3, and a concave cavity 43 is provided on the outer periphery between the first nasal bridge contouring groove and the second nasal bridge contouring groove.

[0041] Specifically, considering the differences in users' faces, the design adapts to various body types through the combination of the first nose bridge contouring groove 41, the second nose bridge contouring groove 42, and the concave cavity 43. This ensures both wearing comfort and stability.

[0042] In one specific embodiment, the drug delivery device loading part 5 includes a raised outer peripheral wall 51 disposed on the extended face-fitting layer, and a loading groove 52 for loading the drug delivery device is formed in the raised outer peripheral wall; at least one anti-mistake coupling rib 510 is provided on the inner ring wall of the raised outer peripheral wall 51, and the drug delivery device 200 is provided with an anti-mistake coupling groove 201 that corresponds one-to-one with the anti-mistake coupling rib.

[0043] Specifically, in order to accommodate the delivery device 200, a loading groove 52 is designed, and the different specifications of the raised outer peripheral wall 51 are designed to meet the loading requirements of various delivery devices 200.

[0044] In addition, to ensure the relativity between the through-window 50 and the medicine outlet 300, a foolproof matching design of foolproof connecting rib and foolproof connecting groove 201 is adopted to meet the foolproof matching assembly requirements.

[0045] In one specific embodiment, the drug delivery device 200 includes a control host 210 and an nebulizer body disposed on the control host 210. The nebulizer body has an nebulizer base 220 and a drug chamber 230 for supplying liquid medicine to the nebulizer base. The drug outlet is an atomizing plate 6 disposed on the nebulizer base. The atomizing plate 6 is electrically connected to the control host. The drug chamber has a supply channel for supplying liquid medicine to the atomizing plate.

[0046] The structure and operating principle of the nebulizer are existing technologies. The structure and principle of the micro-mesh nebulizer will not be elaborated here. It is only necessary to ensure that the mechanism of the nebulizer that supplies the nebulized medicine to the wearer is within the scope of protection of this case.

[0047] In one specific embodiment, the atomizer body is detachably connected to the control unit.

[0048] The detachable connector can be a snap-fit ​​connector, a magnetic connector, or other similar designs. This design satisfies the detachable connection requirements of both devices, making it convenient to disassemble the atomizer body for drug dispensing or cleaning.

[0049] In one specific embodiment, the medication cartridge and the atomizer base are detachably connected. This design allows for separation of the two components, using either a snap-fit ​​or magnetic connection. This enables the medication cartridge to be cleaned and reused repeatedly, or to be replaced with a disposable cartridge.

[0050] In one specific embodiment, the wearable body 100 is an integrally molded structural component consisting of an adhesive layer, an extended face-fitting layer, and a drug delivery device loading part.

[0051] Specifically, the main body 100 is made of elastic material, generally silicone or similar materials, and is formed by one-piece injection molding to meet the needs of mass production.

[0052] As described above, the wearable body effectively accommodates the medication delivery device, offering superior comfort and an aesthetically pleasing appearance. It ensures a snug fit, support, and comfort, making it suitable for various body types. The one-piece molding process facilitates mass production, while also allowing for convenient, efficient, and flexible assembly.

[0053] The term "comprising" or any other similar term is intended to cover non-exclusive inclusion, such that a process, method, article, or apparatus / device that comprises a list of elements includes not only those elements but also other elements not expressly listed, or elements inherent in such process, method, article, or apparatus / device.

[0054] The technical solution of this utility model has been described in conjunction with the preferred embodiments shown in the accompanying drawings. However, it will be readily understood by those skilled in the art that the protection scope of this utility model is obviously not limited to these specific embodiments. Without departing from the principle of this utility model, those skilled in the art can make equivalent changes or substitutions to the relevant technical features, and the technical solutions after these changes or substitutions will all fall within the protection scope of this utility model.

Claims

1. A continuous drug delivery respiratory wearer, characterized in that: Includes the wearer and the delivery device; The wearing body includes a cover, which includes a fitting layer and two extended face-fitting layers disposed on the fitting layer. Each of the extended face-fitting layers has an ear-hook slot. The fitting layer includes a raised chamber for covering the oral cavity and nasal cavity, and a fitting periphery surrounding the raised chamber and fitting the cheek. The wall of the raised chamber has at least one ventilation channel. At least one of the extended face-fitting layers has an exposed drug delivery device loading part for detachably mounting the drug delivery device. The drug delivery device loading part has a through window that connects the extended face-fitting layer and the raised chamber. The drug delivery device is disposed within the drug delivery device loading section, and the drug delivery device has an exposed dispensing end that is aligned and matched with the through-window.

2. The continuous drug delivery respiratory wearer according to claim 1, characterized in that: The outer edge of the fitting is adjacent to the raised cavity and is provided with a first nasal bridge conforming fitting groove and two fitting skirts on both sides of the first nasal bridge conforming fitting groove.

3. The continuous drug delivery respiratory wearer according to claim 2, characterized in that: The outer edge of the fitting is provided with a second nasal bridge conforming fitting groove at one end away from the raised cavity, and the outer edge of the fitting is provided with a concave cavity between the first nasal bridge conforming fitting groove and the second nasal bridge conforming fitting groove.

4. The continuous drug delivery respiratory wearer according to claim 1, characterized in that: The drug delivery device loading section includes a raised outer peripheral wall disposed on the extended face mask layer, and a loading groove for loading the drug delivery device is formed in the raised outer peripheral wall. At least one anti-mistake fitting rib is provided on the inner ring wall of the protruding outer peripheral wall, and the drug delivery device is provided with anti-mistake fitting grooves that correspond one-to-one with the anti-mistake fitting ribs.

5. The continuous drug delivery respiratory wearer according to claim 4, characterized in that: The drug delivery device includes a control host and an nebulizer body disposed on the control host. The nebulizer body has an nebulizer base and a drug chamber for supplying liquid medicine to the nebulizer base. The drug outlet is an nebulizing plate disposed on the nebulizer base. The nebulizing plate is electrically connected to the control host. The drug chamber has a supply channel for supplying liquid medicine to the nebulizing plate.

6. The continuous drug delivery respiratory wearer according to claim 5, characterized in that: The atomizer body is detachably connected to the control host.

7. The continuous drug delivery respiratory wearer according to claim 5, characterized in that: The medicine container is detachably connected to the nebulizer base.

8. A continuous drug delivery respiratory wearer according to any one of claims 1 to 7, characterized in that: The wearable body is an integrally molded structural component consisting of the adhesive layer, the extended face-fitting layer, and the drug delivery device loading part.

Images